A Practical Approach to Quantitate Hepatic Excretory Function 1 by Bircher, Johannes & Hacki, Walter
YALE JOURNAL OF BIOLOGY AND MEDICINE 3, 196-201 (1974)
A Practical Approach to Quantitate Hepatic Excretory Function'
JOHANNES BIRCHER2 AND WALTER HACKI3
Department of Clinical Pharmacology, University of Berne, Switzerland
Received March 22, 1974
A statistical comparison of different BSP tests was carried out in normal subjects
and in patients with various degrees of chronic liver damage. Only the logarithm of
the BSP retention correlated linearly with the physiologically more meaningful
determination of the maximal excretory capacity of the liver (BSP Tm, Wheele's
method). A double logarithmic transformation was required to correlate the second
exponential component of the BSP plasma disappearance curve (k2) with the
BSP Tm. When the limitations of these methods are kept in mind, the observed
statistical relationships can be used to express hepatic functional deterioration in more
physiological terms.
In patients with pulmonary or renal disease it is an established procedure to
use quantitative function tests to follow the progression of the disease and/or to
assess the effects of various forms of treatment. By contrast, analogous approaches
to studying patients with liver diseases have been used only rarely. The need to
develop quantitative tests of hepatic function has not been pressing because specific
and effective therapy has not been available. Recently, however, clinical trials have
accumulated evidence to suggest that chronic active liver disease may be success-
fully treated with corticosteroid hormones (1-3). Consequently quantiative clinical
tests to measure partial hepatic functions have become more desirable.
With the presently available sulfobromophthalein-or BSP-tests-as in many
other areas of medicine-there is an inverse relationship between simplicity of the
procedures and specificity of the information they can give (Table 1). Indeed, only
the measurement of the hepatic transport maximum for BSP can truly be considered
to represent a quantitative expression of hepatic excretory function (4). In practice,
the test based on Wheeler's method is cumbersome and time-consuming and, there-
fore, seems ill-suited for the clinical routine. By contrast, the coventional BSP
retention test is widely used and generally accepted. It is technically simple and
empirically quite sensitive for the detection of liver disease (5). Consideration
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TABLE 1
BSP TESTS ITSED TO ASSESS ILEPATIC F1ITNCrTIO.N. "SIECIFITY' IIMPLIES
TIIAT THE: INFOR-MATION PIIOV-IDEI) BY TllE'. Tl'EST ExiPiRESSEo'S
CIIANGES IN EXCIIEToRY Fu-NCTION QUANrTITATIVELY
Simplicity of " )pecifitv" of
Test procedoure inoformoation
I BSP r'eteitioII (5) ++ -
2 BSP I)IaSIIIa disa1p)earance - + +
curve (6--8)
3 13SP transport m11aximum111 (4) - ++
of its physiological rationale, however, illustrates that the results must be inter-
preted with caution.
The concentration of BSP in the plasma used for the 45-min BSP retention
(C1,5) may be calculated as follows:
BSPi.;. - BSP(xer.
VD
The equation shows that C45, is directly proportional to the difference of the
amounts of BSP injected (BSPi,,j.) and excreted (BSPQ\Cr.) and inversely pro-
portional to the volume of distribution of BSP (VD). The injected quantity of BSP
is standardized to 5 mg/kg body wt. Only the proportion excreted by the liver
is related to hepatic function. Since, however, the concentration of BSP offered
to the liver varies continuously throughout the test, it cannot be expected that the
amount of BSP excreted during 45 min bears any simple relationship to the excre-
tory capacity of the liver. The well-established complexities of hepatic handling
of BSP further complicate the problem: Apart from BSP binding to plasma and
intrahepatic acceptor proteins, at least conjugation and reflux into the plasma have
to be considered as well. The volume of distribution appearing in the denominator
is larger than the plasma volume, and its relation to disease processes is not ade-
quately defined. These aspects, therefore, limit interpretation of the results to an
empirical and statistical basis.
The third test used to assess liver function is an analysis of the BSP plasma
disappearance curve. If frequent samples are taken, the curve may often be de-
scribed as a double exponential function (6, 7). Despite the formulation of kinetic
models (8), the physiological basis for these curves has remained insufficiently
understood.
Consequently, studies in our department were directed to further evaluate the
BSP retention and the BSP plasma disappearance curve (5, 9). In a group of pa-
tients with various liver diseases and in normal control subjects, the three tests
have been carried out in one session. A comparison of the results revealed that
the simple tests may be interpreted in terms of specific partial functions.
The BSP disappearance curves were measured after the intravelnous injection
of 5 mg/kg of BSP within 30 sec. Blood samples were obtained at 3, 5, 7, 10,
15, 20, 25, 30, 35, 40, and 45 min after the beginning of the injection. The last
sample was used to calculate BSP retention assuming an initial concentration of
10 mg/100 ml.
The BSP Tim was determined indirectly with the two-infusion method as de-
scribed by Preisig et al. (10). The principles of this method are based on the idea,
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that with the chosen experimental conditions, the intravenously infused BSP is
either distributed within its volume of distribution-plasma volume (PV) and
hepatic storage compartment (S)-or excreted at the rate (Tm) which is maximal
for the liver to be studied (4).
The distribution of BSP can be calculated as product of the rate of change in
plasma concentration (AC/At) and the volume of distribution (PV + S). Conse-
quently, the equation may be written as:
Infusion = Tm + Ac/At (PV + S).
As only the rate of infusion and the plasma concentrations can be measured
there remain two unknowns (Tm and S). Two different infusions, therefore, have
to be administered in order to produce two equations with two unknowns, which
then can be solved. The practical application of the test requires consideration of
many details which have been discussed elsewhere (4, 11).
The first finding of our comparative analysis consisted of the empirical fact that
only the logarithms of the BSP-retention were linearly correlated with the excretory
capacity of the liver as revealed by the BSP Tm (Fig. 1). This type of relationship
implies that the degree of abnormality revealed by the BSP retention has no direct
proportionality to the functional deterioration of a diseased liver. The higher the
measured BSP retention, the more sensitive it is in revealing changes of excretory
function. This observation led to a definition of new BSP retention units. They
were constructed to express linearly functional deterioration of the excretory system
and can be read directly from the nomogram of Fig. 2. The normal mean value
was regarded as zero retention. The range up to 1.0 retention unit was taken as
normal, whereas the higher values correspond to directly proportional decreases
in the excretory capacity of the liver for BSP. Application of such retention units
to clinical problems should always take into account, however, that they were de-
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FIG. 1. The correlation of BSP retention and BSP Tm has to be semilogarithmic to yield
a straight regression line. The points refer to control persons, the triangles to patients with
cirrhosis of the liver, and the crosses to patients with various other liver diseases. (Reproduced
with the kind permission of the Schweiz. Med. Wochereschr.)
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fined on a statistical and not a pathophysiologically recognized relationship. Their
justification, therefore, remains empirical.
A similar analysis was carried out with the BSP plasma disappearance curve.
Its most important finding consisted in the close correlation between the logarithms
of the second component (k2) of the disappearance curve (Fig. 3) and the BSP
transport maximum, suggesting that k2 is mainly determined by the excretory capac-
ity of the liver (Fig. 4). In support of this assumption there was no significant













FIG. 2. Nomogram to show the relationship between the conventional 45-min BSP retention
(in %) and the newly defined arbitrary BSP retention units, which express linearly hepatic
functional deterioration. The normal range is below 1.0 retention unit. (Reproduced with the
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FIG. 3. k2 as defined in our laboratory, depends on BSP concentrations between 30 and
45 min after the injection of 5 mg/kg BSP. For comparison, also the initial part of the plasma
disappearance curve is shown.
199BIRCHER AND HACKI
ICG-infusion and extraction technique (12). Physiologically, ko could be explained
on the basis of a two-compartment model, where, in addition, the actual BSP plasma
concentrations had to be taken into account. Even though the details, especially
the mathematical derivation, are described elsewhere (9), the model may be re-
garded as an adequate basis to jutify the use of k2 for estimations of BSP Tm.
In practice, this test requires only four determinations of BSP plasma concentra-
tions, 30, 35, 40, and 45 min after the injection of BSP. The value of k2 is calculated
from the graphically read half-life (T1I2) provided three of the four points can
be accurately fitted to a straight line (k2 = 0.693/T,1/2). When this condition is
not fulfilled, the resulting k2 is inaccurate and should not be used. In our experience,
this difficulty occurred in 39% of normal subjects but only in 10% of patients
with impaired function. Consequently this procedure is more suitable to assess
degrees of abnormality than to define a normal population. The values for k2 ob-
tained with this method, can be converted to "estimated" BSP Tm values with
the aid of another nomogram, depicted in Fig. 5. The specific conditions suggested
for the determination of k2 were found by trial and error. The failures to get a
straight line between 30 and 45 min after injection of BSP in a high percentage
of control subjects were due to the relatively rapid disappearance of BSP from
the blood leading to low plasma concentrations which were difficult to measure
accurately enough. In patients with impaired liver function, a hump in the curve
occasionally rendered k, inaccurate. Severe cholestasis or the Dubin-Johnson syn-
drome usually were associated with a ko approaching zero. The secondary rise in
plasma BSP concentration often seen in these cases generally occurred after 45
min and consequently did not interfere with the assessment of k2.
If further studies on a larger scale confirm the results obtained in our laboratory,
the use of BSP k2 and of BSP-retention units should be valuable in the follow-up
of patients treated for chronic liver disease. Both tests are simple enough for the
clinical routine and give information about quantitative aspects of the excretory
function of the liver. Because of its better established physiological basis, the BSP
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FIG. 4. The correlation between BSP k2 and Tm is curvilinear and gives a straight line
only if a double logarithmic plot is used. The open circles represent control persons, the
closed circles symbolize patients with histologically proven cirrhosis of the liver, and the crosses
are derived from cases represesenting various chronic liver diseases.
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FIG. 5. The nomogram for the conversion of k2 to "estimated" BSP Tnm is based on the
regression line shown in Fig. 4 and on a two-compartment model exhibiting saturation kinetics
at the excretory step. It allows estimations of the BSP Tmti on the basis of k2, provided the
experimental findings are good enough for the calculation of k,.
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